Princeton Alpha Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,870
Closed -$310K 790
2016
Q3
$310K Buy
+4,870
New +$310K 0.06% 486
2015
Q3
Sell
-3,350
Closed -$211K 825
2015
Q2
$211K Buy
+3,350
New +$211K 0.04% 581
2014
Q4
Sell
-8,530
Closed -$250K 766
2014
Q3
$250K Buy
8,530
+1,892
+29% +$55.5K 0.06% 493
2014
Q2
$258K Buy
+6,638
New +$258K 0.05% 495